Selecting a Final Vendor to Deliver the IC Product and Service Eastern Medical Center Choosing an Infection Control Vendor Will the new IC process will impact the work flow in cross department areas surgery and ICU ? The Center for Disease Control approximates that two million hospital patients each year contract infections unconnected to the conditions for which they were admitted. These infections cause roughly 90 thousand deaths and escalate patient-care costs by 4.5 to 5.7 billion annually. EMC has reached the final stages of evaluating and selecting a Infection control vendor Evaluating Infection Control Vendors for EMC Evaluating Infection Control Vendors for EMC Change Management CMS National Patient Safety Goals (NPSG)/Joint Commission CDC/National Healthcare Safety Network (NHSN) Health Care-Associated Infection Prevention and Control Act 52 of 2007 HHS Action Plan for HAI Prevention The American Recovery and Reinvestment Act (ARRA) Pennsylvania Health Care Cost Containment Council (PHC4) Assist in the detection and prevention of infections Have systems in place to provide timely infection control surveillance and reporting. Be CDC NHSN data submission ready as well as allow for data submission to state and payer mandated programs. The Successful Vendors Software Must The Project Manager will be responsible for supervising the change management process. Minor changes within scope can be approved by the Project Manager. Any change affecting an external contractor/sub- contractor would need to be reviewed with that contractor in regards to any necessary contract revisions and/or payments, etc. Changes of scope and contract revisions would require the approval of the ICI Change Control Board). The decision whether to accept or reject a change would be based on the following criteria: Is the change unavoidable (i.e. legislative changes, mergers, acquisitions, etc)? or Does the change increase the overall benefit to our organization (taking into account any impact on the costs, benefits, timescales and risks)? Additionally, Is the Project Team able to make such a change?...and Is the change best done now, or would it be more beneficial to defer it until the current work is complete? 2 separate rating systems Vendor Evaluation Vendor Ranking Reduced likelihood of blanket answers Delphi Method Anonymous responses from EMC participants Averaged together 2 Vendors Declined Premier RL Solutions 5 Vendors Completed a RFP VecnaMedical Quantros Theradoc BD CareFusion Carefusion MedMind Q uantros IC Insight Vecna Medical Theradoc BD Company Background System Function53343 Technical44433 Security and Privacy Pricing34253 Backup/ Recovery55434 Quality of Service55534 Support55335 Customi-zation43233 Integration44444 Training55434 References55435 TOTAL SCORE/ CategoryCriteria Carefusion MedMined Quantros Vecna Medical Theradoc BD Software Product Return on Investment Maximum Customer References Maximum Ease of Use Maximum Compatibility Maximum Fitness for Use Maximum Section Total Maximum Implementation Services Implementation Plan & Methodology Maximum Documentation Maximum Training Maximum Section Total Maximum PricingMaximum Grand TotalMaximum For the Implementation Annual Subscription Fee: $150 X 300 licenses beds = $40,000 (Includes unlimited seats and support) Implementation Fees: $15,000 Interfaces -$25,000 ADT Lab Pharmacy Surgery year cost estimates 1st Year Costs: $80,000 Year 2 - 5: $40,000 Clinical (ICP) : Evaluation of each vendor response, participation in onsite visits and reference calls participation in vendor demos make recommendation of best fit based on clinical needs IT - Evaluation of each vendor response review of IT requirements and interface specs Review of support agreement participation in demo and reference calls provide recommendations for best vendor fit based on IT requirements and resources needed Finance -review of responses to pricing determination of operating versus capital budget review of Return on Investment from the vendor Recommend best vendor fit based on pricing and payment methods (monthly versus annual) Legal -review RFP responses and provide guidance prior to contract negotiation Technical Considerations No EMR Interface with EMCs: Sunquest Laboratory (Lab/Microbiology) WindoPath (Pathology) ORSOS One-Call (Surgery) Meditech Pharmacy Meditech ADT Software as a Service (SaaS) Technical Considerations Data Systems Type Devices Testing and Validation Implementation Vendor Size Consideration Explosion of Customer Base Appropriate staff availability Implementation Resources to Support Desire Large Partner Niche Specific Comprehensive division of Large Vendor Assess software with respect to requirements We will require acceptance testing and withhold 25% of the payment until we sign off on acceptance testing. How? Process for acceptance testing Installation testing Interface testing Component/Module Testing Final System testing Time commitment Resources needed Test script Key areas of information updates When? After test environment is set up and clinical signoff Part of the test environment or live environment Unacceptable results during acceptance testing? Preliminary result vs final result updates, resistance and sensitivity testing on antibiotics Does not dovetail precisely with the infection control processes Makes processes more difficult to do than before Causes infection control processes to take longer than previously Makes additional infection control processes necessary, while making other processes obsolete The Role of Acceptance Testing The Role of Acceptance Testing Vendor Selection CategoryCriteria CareFusion MedMined Quantros IC Insight Software Product Return on Investment Maximum Customer References Maximum 5 55 Ease of Use Maximum 5 55 Compatibility Maximum 5 44 Fitness for Use Maximum 5 99 Section Total Maximum Implementation Services Implementation Plan & Methodology Maximum Documentation Maximum Training Maximum Section Total Maximum PricingMaximum Grand TotalMaximum Carefusion MedMind Q uantros IC Insight Company Background55 System Function53 Technical44 Security and Privacy45 Pricing34 Backup/ Recovery55 Quality of Service55 Support55 Customi-zation43 Integration44 Training55 References55 TOTAL SCORE/ Rules based engine .. Issue smart alerts .. Fast implementation Always On surveillance Provide secure data access Easy to use, with access to more than 1,000 rules, via the community library Minimize alert fatigue, ensure active relevance Quickly up and running in a comprehensive medication surveillance system Transparently monitors 24/7 to ensure medication safety at all times A HIPAA compliant secure SSL, Point-to Point system ensures secure data transfer Has a solution feature that sends the hospital data off-site to be compiled and analyzed by Cardinals epidemiologists. This analysis implements a form of quality control, training and guidelines set by Cardinals epidemiologist instead of the hospital Infection Control Practioners. 1. It uses a list of rules as defined by the hospital to look for variances by using this feature departmental variances and conflicts can be diminished. 2. This will improved infection workflow management 3. The clinicians will be empowered to anticipate, identify and prevent infections. This will ensure adherence to best practices. 4. Dashboard feature presents monitoring suspected cases on screen. EMCs Vendor Choice was not based on the Least costly Vendor, it was based on two things specifically. The Hospitals desire to control its own work flow and data and use. To ensure best practices and workflow through the use EMC rules via the Quantros rules based engine feature. Implementation/Interface issues Product was not easy to use Product support/training options did not meet the needs of our staff Poor value for the money Conflict of Interest Vendor references indicated frequent unscheduled downtimes Product features did not meet our immediate or future needs KLAS Report Infection Control: Improving Patient Care and Reimbursements Released 06/08/2009 tp://www.klasresearch.com/store/reportdetail.aspx?productid=537 tp://www.klasresearch.com/store/reportdetail.aspx?productid=537 The American Recovery and Reinvestment Act of 2009, Public Law (ARRA) was signed into law on February 17, https://www.cfda.gov/index?s=program&mode=form&tab=step1&id=ea9ba 8ca3284e93605ab0865d2034c33 Joint commission Quantros web Carefusionservices-categories/infection-prevention/medmined-benchmarking.aspxhttp://www.carefusion.com/products-and-services/products- services-categories/infection-prevention/medmined-benchmarking.aspx Quantros IC Insight